Difluprednate
Back to searchMolecule Structure
Scientific Name
Difluprednate
Description of the Drug
Difluprednate is a topical corticosteroid used for the symptomatic treatment of inflammation and pain associated with ocular surgery.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06781
http://www.drugbank.ca/drugs/DB06781
Brand Name(s)
Durezol
Company Owner(s)
Cipla Ltd, Amneal Eu Ltd, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4580 | |
| PharmGKB | PA165958405 | |
| Human Metabolome Database | HMDB0015676 | |
| DrugBank | DB06781 | |
| PubChem: Thomson Pharma | 14811237 | 16650119 |
| PubChem | 443936 | |
| Nikkaji | J15.820H | |
| EPA CompTox Dashboard | DTXSID0046773 | |
| DrugCentral | 3142 | |
| ChemicalBook | CB7458293 | |
| Guide to Pharmacology | 7474 | |
| rxnorm | DUREZOL | DIFLUPREDNATE |
| KEGG Ligand | C12695 | |
| ChEBI | 31485 | |
| ZINC | ZINC000004212945 |
